Details of the Drug Formulations

General Information of Drug (ID: DMI7FVQ)

• Drug Name: Metyrapone Drug Info
• Synonyms: MYT; Mepyrapone; Metapirone; Metapyron; Methapyrapone; Methbipyranone; Methopirapone; Methopyrapone; Methopyrinine; Methopyrone; Metirapona; Metopiron; Metopirone; Metopyrone; Metroprione; Metyrapon; Metyraponum; Alliance Brand of Metyrapone; Metyrapone Alliance Brand; Metyrapone Novartis Brand; Novartis Brand of Metyrapone; Su 4885; METOPIRONE (TN); Metirapona [INN-Spanish]; Metopirone (TN); Metyraponum [INN-Latin]; Su-4885; Metyrapone (JP15/USP/INN); Metyrapone [USAN:INN:BAN:JAN]; 1,2-Di-3-pyridyl-2-methyl-1-propanone; 2-Methyl-1,2-bis(3-pyridyl)-1-propanone; 2-Methyl-1,2-di-3-pyridinyl-1-propanone; 2-Methyl-1,2-di-3-pyridyl-1-propanone; 2-methyl-1,2-dipyridin-3-yl-propan-1-one; 2-methyl-1,2-dipyridin-3-ylpropan-1-one

Indication

Disease Entry	ICD 11	Status	REF
Cushing disease	5A70	Approved	[1] , [2]

• Therapeutic Class: Antimetabolites
• Cross-matching ID:
  PubChem CID: 4174
  ChEBI ID: CHEBI:44241
  CAS Number: 54-36-4
  TTD ID: D0Q9JT
  ACDINA ID: D00426

Full List of Drug Formulations Containing This Drug

Metyrapone 250 mg capsule

Company	Formulation ID	FDA Description
HRA Pharma	F14017	Ethyl vanillin; Propylparaben sodium; Glycerin; Titanium dioxide; Gelatin; Polyethylene glycols
Laboratoire HRA Pharma	F14018	Ethyl vanillin; Propylparaben sodium; Glycerin; Titanium dioxide; Gelatin; Polyethylene glycols

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5224).
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 012911.